Crucef 250mg/31.25mg Injection
Marketer
Aronex Life Sciences Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Crucef 250mg/31.25mg Injection
Cefixime and Sulbactam 250mg/31.25mg Injection is a dual-action antibiotic. It's indicated for a range of bacterial infections, effectively combating microbial growth and preventing infection spread. Administration must be solely under a physician's direction. Complete the prescribed treatment regimen; premature cessation may reduce efficacy. Report missed doses immediately. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Seek immediate medical attention if side effects worsen or an allergic reaction (rash, itching, swelling, dyspnea) occurs. Inform your doctor about all current medications, including over-the-counter drugs, before commencing treatment. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to potential increased drowsiness. While driving impairment is usually minimal, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration will aid recovery. Your doctor may order tests to monitor the medication's effects.
Uses of Crucef 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Crucef 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Crucef 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Crucef 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Crucef 250mg/31.25mg Injection works:
Ceftriaxone 250mg/31.25mg (Crucef) injection unites the antibiotic ceftriaxone with the beta-lactamase inhibitor tazobactam. Ceftriaxone's antibacterial action disrupts bacterial cell wall synthesis, hindering bacterial viability. Tazobactam counters bacterial resistance mechanisms, bolstering ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Crucef 250mg/31.25mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Crucef 250mg/31.25mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Crucef 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Crucef 250mg/31.25mg Injection may induce drowsiness, visual disturbances, or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Crucef 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Administering Crucef 250mg/31.25mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Seek medical advice. Dosage alteration for Crucef 250mg/31.25mg Injection is not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Crucef 250mg/31.25mg Injection :
Should you forget a dose of Crucef 250mg/31.25mg Injection, seek your physician's advice.
Facts to Know About Crucef 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Antimicrobial agents |
3,018 People bought this recently